Confusion Persists Over US Biosimilar Interchangeability

Urgent Need For Clarity Over Misperceptions Linked To Unique US Designation, Paper Insists

 
• By Dave Wallace
  
Vials Question Marks Confusion
The US interchangeability designation has led to confusion over biosimilars • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics